ArticleJournal of racial and ethnic health disparities2026
Racial Disparities in Shared Decision Making Among Prostate Cancer Patients: A National Study.
Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shared decision-making (SDM) plays an important role in patients with prostate cancer due to the complexities of screening and treatment. This study assessed the racial and ethnic disparities in SDM in patients diagnosed with prostate cancer in the United States. This cross-sectional analysis utilized 2014-2021 Medical Expenditure Panel Survey (MEPS) data. Male patients ≥ 18 years old with a diagnosis of prostate cancer were included. The Consumer Assessment of Healthcare Providers and Systems survey was used to operationalize the SDM, with scores categorized as poor (4-8), average (9-11), and optimal SDM (12). Multinomial regression model was used to analyze the racial and ethnic disparities in SDM among prostate cancer patients after adjusting for other covariates guided by the Andersen Behavioral Model. We identified 1.39 million (95%CI: 1.3-1.49) patients with prostate cancer between 2014 and 2021. The predominant race was White (64.4%), followed by African American (20.65%) and Hispanic (10.60%). Overall, 41.56% of patients reported optimal SDM scores, 49.82% reported average, and 8.62% reported poor SDM scores. The multinomial model revealed that the Hispanic patients had significantly higher odds of poor SDM scores than White patients (adjusted odds ratio:3.23, 95% CI: 1.14-9.46). Compared to optimal SDM, African American and White patients showed no significant differences in the odds of reporting poor or average SDM (p = 0.14 and p = 0.09, respectively). This study found that one in ten patients reported poor SDM for prostate cancer, with a higher likelihood of poor SDM among Hispanics. Concerted efforts are needed to improve the cultural competency and communication skills aimed at Hispanic patients to improve patient-centered care.
Indexed as
Identifiers
42082839What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.